139 related articles for article (PubMed ID: 35649469)
1. Expression and activation of the ketone body receptor HCAR2/GPR109A promotes preservation of retinal endothelial cell barrier function.
Abdelrahman AA; Powell FL; Jadeja RN; Jones MA; Thounaojam MC; Bartoli M; Al-Shabrawey M; Martin PM
Exp Eye Res; 2022 Aug; 221():109129. PubMed ID: 35649469
[TBL] [Abstract][Full Text] [Related]
2. GPR109A as an anti-inflammatory receptor in retinal pigment epithelial cells and its relevance to diabetic retinopathy.
Gambhir D; Ananth S; Veeranan-Karmegam R; Elangovan S; Hester S; Jennings E; Offermanns S; Nussbaum JJ; Smith SB; Thangaraju M; Ganapathy V; Martin PM
Invest Ophthalmol Vis Sci; 2012 Apr; 53(4):2208-17. PubMed ID: 22427566
[TBL] [Abstract][Full Text] [Related]
3. Expression and localization of GPR109A (PUMA-G/HM74A) mRNA and protein in mammalian retinal pigment epithelium.
Martin PM; Ananth S; Cresci G; Roon P; Smith S; Ganapathy V
Mol Vis; 2009; 15():362-72. PubMed ID: 19223991
[TBL] [Abstract][Full Text] [Related]
4. Erythropoietin maintains VE-cadherin expression and barrier function in experimental diabetic retinopathy via inhibiting VEGF/VEGFR2/Src signaling pathway.
Liu D; Xu H; Zhang C; Xie H; Yang Q; Li W; Tian H; Lu L; Xu JY; Xu G; Liu K; Sun X; Xu GT; Zhang J
Life Sci; 2020 Oct; 259():118273. PubMed ID: 32800831
[TBL] [Abstract][Full Text] [Related]
5. Bone Morphogenetic Protein-4 Impairs Retinal Endothelial Cell Barrier, a Potential Role in Diabetic Retinopathy.
Darwish NHE; Hussein KA; Elmasry K; Ibrahim AS; Humble J; Moustafa M; Awadalla F; Al-Shabrawey M
Cells; 2023 Apr; 12(9):. PubMed ID: 37174679
[TBL] [Abstract][Full Text] [Related]
6. Exploring the role of Müller cells-derived exosomes in diabetic retinopathy.
Gad MS; Elsherbiny NM; El-Bassouny DR; Omar NM; Mahmoud SM; Al-Shabrawey M; Tawfik A
Microvasc Res; 2024 Jul; 154():104695. PubMed ID: 38723843
[TBL] [Abstract][Full Text] [Related]
7. β-Hydroxybutyrate protects from alcohol-induced liver injury via a Hcar2-cAMP dependent pathway.
Chen Y; Ouyang X; Hoque R; Garcia-Martinez I; Yousaf MN; Tonack S; Offermanns S; Dubuquoy L; Louvet A; Mathurin P; Massey V; Schnabl B; Bataller RA; Mehal WZ
J Hepatol; 2018 Sep; 69(3):687-696. PubMed ID: 29705237
[TBL] [Abstract][Full Text] [Related]
8. Bone Morphogenetic Protein-2 Induces Non-Canonical Inflammatory and Oxidative Pathways in Human Retinal Endothelial Cells.
Al-Shabrawey M; Hussein K; Wang F; Wan M; Elmasry K; Elsherbiny N; Saleh H; Yu PB; Tawfik A; Ibrahim AS
Front Immunol; 2020; 11():568795. PubMed ID: 33584642
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic regulation of VE-cadherin with a novel oligonucleotide drug for diabetic eye complications using retinopathy mouse models.
Ting KK; Zhao Y; Shen W; Coleman P; Yam M; Chan-Ling T; Li J; Moller T; Gillies M; Vadas MA; Gamble JR
Diabetologia; 2019 Feb; 62(2):322-334. PubMed ID: 30443753
[TBL] [Abstract][Full Text] [Related]
10. Molecular analysis of blood-retinal barrier loss in the Akimba mouse, a model of advanced diabetic retinopathy.
Wisniewska-Kruk J; Klaassen I; Vogels IM; Magno AL; Lai CM; Van Noorden CJ; Schlingemann RO; Rakoczy EP
Exp Eye Res; 2014 May; 122():123-31. PubMed ID: 24703908
[TBL] [Abstract][Full Text] [Related]
11. VEGF receptor 2 inhibitor nintedanib completely reverts VEGF-A
Deissler HL; Stutzer JN; Lang GK; Grisanti S; Lang GE; Ranjbar M
Exp Eye Res; 2020 May; 194():108004. PubMed ID: 32184103
[TBL] [Abstract][Full Text] [Related]
12. Bone morphogenetic protein 2: a potential new player in the pathogenesis of diabetic retinopathy.
Hussein KA; Choksi K; Akeel S; Ahmad S; Megyerdi S; El-Sherbiny M; Nawaz M; Abu El-Asrar A; Al-Shabrawey M
Exp Eye Res; 2014 Aug; 125():79-88. PubMed ID: 24910902
[TBL] [Abstract][Full Text] [Related]
13. Erythropoietin protects the inner blood-retinal barrier by inhibiting microglia phagocytosis via Src/Akt/cofilin signalling in experimental diabetic retinopathy.
Xie H; Zhang C; Liu D; Yang Q; Tang L; Wang T; Tian H; Lu L; Xu JY; Gao F; Wang J; Jin C; Li W; Xu G; Xu GT; Zhang J
Diabetologia; 2021 Jan; 64(1):211-225. PubMed ID: 33104828
[TBL] [Abstract][Full Text] [Related]
14. Chemokine mediated monocyte trafficking into the retina: role of inflammation in alteration of the blood-retinal barrier in diabetic retinopathy.
Rangasamy S; McGuire PG; Franco Nitta C; Monickaraj F; Oruganti SR; Das A
PLoS One; 2014; 9(10):e108508. PubMed ID: 25329075
[TBL] [Abstract][Full Text] [Related]
15. Protection of blood retinal barrier and systemic vasculature by insulin-like growth factor binding protein-3.
Jarajapu YP; Cai J; Yan Y; Li Calzi S; Kielczewski JL; Hu P; Shaw LC; Firth SM; Chan-Ling T; Boulton ME; Baxter RC; Grant MB
PLoS One; 2012; 7(7):e39398. PubMed ID: 22792172
[TBL] [Abstract][Full Text] [Related]
16. Relative Importance of Different Elements of Mitochondrial Oxidative Phosphorylation in Maintaining the Barrier Integrity of Retinal Endothelial Cells: Implications for Vascular-Associated Retinal Diseases.
Eltanani S; Yumnamcha T; Gregory A; Elshal M; Shawky M; Ibrahim AS
Cells; 2022 Dec; 11(24):. PubMed ID: 36552890
[TBL] [Abstract][Full Text] [Related]
17. PHD2 attenuates high-glucose-induced blood retinal barrier breakdown in human retinal microvascular endothelial cells by regulating the Hif-1α/VEGF pathway.
Li J; Lu X; Wei L; Ye D; Lin J; Tang X; Cui K; Yu S; Xu Y; Liang X
Inflamm Res; 2022 Jan; 71(1):69-79. PubMed ID: 34773469
[TBL] [Abstract][Full Text] [Related]
18. Melatonin Maintains Inner Blood-Retinal Barrier by Regulating Microglia
Tang L; Zhang C; Lu L; Tian H; Liu K; Luo D; Qiu Q; Xu GT; Zhang J
Front Immunol; 2022; 13():831660. PubMed ID: 35371022
[TBL] [Abstract][Full Text] [Related]
19. Osteopontin-induced vascular hyperpermeability through tight junction disruption in diabetic retina.
Someya H; Ito M; Nishio Y; Sato T; Harimoto K; Takeuchi M
Exp Eye Res; 2022 Jul; 220():109094. PubMed ID: 35490836
[TBL] [Abstract][Full Text] [Related]
20. Ketones and pain: unexplored role of hydroxyl carboxylic acid receptor type 2 in the pathophysiology of neuropathic pain.
Boccella S; Guida F; De Logu F; De Gregorio D; Mazzitelli M; Belardo C; Iannotta M; Serra N; Nassini R; de Novellis V; Geppetti P; Maione S; Luongo L
FASEB J; 2019 Jan; 33(1):1062-1073. PubMed ID: 30085883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
